AU2011298340B2 - Rheumatoid arthritis treatment using polyunsaturated long chain ketones - Google Patents
Rheumatoid arthritis treatment using polyunsaturated long chain ketones Download PDFInfo
- Publication number
- AU2011298340B2 AU2011298340B2 AU2011298340A AU2011298340A AU2011298340B2 AU 2011298340 B2 AU2011298340 B2 AU 2011298340B2 AU 2011298340 A AU2011298340 A AU 2011298340A AU 2011298340 A AU2011298340 A AU 2011298340A AU 2011298340 B2 AU2011298340 B2 AU 2011298340B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- compound
- tnf
- ring
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
- C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
- C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1014633.0A GB201014633D0 (en) | 2010-09-02 | 2010-09-02 | Rheumatoid arthritis treatment |
| GB1014633.0 | 2010-09-02 | ||
| PCT/EP2011/065123 WO2012028688A1 (en) | 2010-09-02 | 2011-09-01 | Rheumatoid arthritis treatment using polyunsaturated long chain ketones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2011298340A1 AU2011298340A1 (en) | 2013-03-28 |
| AU2011298340B2 true AU2011298340B2 (en) | 2014-09-25 |
Family
ID=43013608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2011298340A Ceased AU2011298340B2 (en) | 2010-09-02 | 2011-09-01 | Rheumatoid arthritis treatment using polyunsaturated long chain ketones |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9682930B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2611432A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6082347B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20130112880A (cg-RX-API-DMAC7.html) |
| CN (2) | CN109893518A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011298340B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2810102A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201014633D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL224963A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012028688A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8778398B2 (en) | 2008-11-04 | 2014-07-15 | Jazz Pharmaceuticals, Inc. | Immediate release formulations and dosage forms of gamma-hydroxybutyrate |
| MX391660B (es) | 2010-03-24 | 2025-03-21 | Jazz Pharmaceuticals Inc | Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas |
| GB201205394D0 (en) | 2012-03-27 | 2012-05-09 | Adlens Ltd | Improvements in or relating to deformable non-round membrane assemblies |
| GB201221329D0 (en) | 2012-11-27 | 2013-01-09 | Avexxin As | Dermatitis treatment |
| GB201313238D0 (en) | 2013-07-24 | 2013-09-04 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| GB201409363D0 (en) * | 2014-05-27 | 2014-07-09 | Avexxin As | Skin cancer treatment |
| GB201501144D0 (en) | 2015-01-23 | 2015-03-11 | Avexxin As | Process for the preparation of a polyunsaturated ketone compound |
| US10398662B1 (en) | 2015-02-18 | 2019-09-03 | Jazz Pharma Ireland Limited | GHB formulation and method for its manufacture |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| US12478604B1 (en) | 2016-07-22 | 2025-11-25 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602513B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11602512B1 (en) | 2016-07-22 | 2023-03-14 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11986451B1 (en) | 2016-07-22 | 2024-05-21 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US12186296B1 (en) | 2016-07-22 | 2025-01-07 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11504347B1 (en) | 2016-07-22 | 2022-11-22 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| UY37341A (es) | 2016-07-22 | 2017-11-30 | Flamel Ireland Ltd | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada |
| CA3037582A1 (en) | 2016-09-21 | 2018-03-29 | Avexxin As | Pharmaceutical composition |
| US20180263936A1 (en) | 2017-03-17 | 2018-09-20 | Jazz Pharmaceuticals Ireland Limited | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders |
| JP7305562B2 (ja) * | 2017-06-16 | 2023-07-10 | アヴェクシン エーエス | 線維性疾患の治療のための組成物および方法 |
| BR112021006027A2 (pt) | 2018-11-19 | 2021-06-29 | Jazz Pharmaceuticals Ireland Limited | formulações de fármaco resistente a álcool |
| BR112021013766A2 (pt) | 2019-03-01 | 2021-09-21 | Flamel Ireland Limited | Composições de gama-hidroxibutirato com farmacocinética melhorada no estado alimentado |
| GB201910644D0 (en) | 2019-07-25 | 2019-09-11 | Coegin Pharma As | Cancer Treatment |
| TW202139986A (zh) | 2020-02-21 | 2021-11-01 | 愛爾蘭商爵士製藥愛爾蘭有限責任公司 | 治療原發性嗜睡症之方法 |
| US20210311022A1 (en) * | 2020-03-27 | 2021-10-07 | Organogenesis, Inc. | Methods, kits and compositions for characterizing an anti-inflammatory response of a product |
| US12582622B2 (en) | 2020-10-08 | 2026-03-24 | Jazz Pharmaceuticals Ireland Limited | Sodium oxybate to treat idiopathic hypersomnia |
| IL305969A (en) * | 2021-03-23 | 2023-11-01 | Organogenesis Inc | Methods kits and compositions for characterizing an anti-inflammatory response of a product |
| US11779557B1 (en) | 2022-02-07 | 2023-10-10 | Flamel Ireland Limited | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics |
| US11583510B1 (en) | 2022-02-07 | 2023-02-21 | Flamel Ireland Limited | Methods of administering gamma hydroxybutyrate formulations after a high-fat meal |
| CN121038779A (zh) | 2023-02-03 | 2025-11-28 | 特瑞斯制药公司 | 每晚一次的低钠羟丁酸盐组合物 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003063878A1 (en) * | 2002-01-29 | 2003-08-07 | Leiv Eiriksson Nyskaping As | Use of polyunsaturated ketones for the treatment of psoriasis |
| WO2006096579A1 (en) * | 2005-03-04 | 2006-09-14 | Abbott Laboratories | Nutritional products for ameliorating symptoms of rheumatoid arthristis |
| US20090192201A1 (en) * | 2008-01-28 | 2009-07-30 | Guillermo Selman-Housein Sosa | Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
| WO2010139482A1 (en) * | 2009-06-04 | 2010-12-09 | Avexxin As | Glomerulonephritis treatment |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670465A (en) * | 1986-05-21 | 1987-06-02 | Syntex (U.S.A.) Inc. | Arachidonic acid analogs |
| JPH0987176A (ja) | 1995-09-26 | 1997-03-31 | Shiseido Co Ltd | 糸球体腎炎抑制剤 |
| JPH09268153A (ja) | 1996-04-02 | 1997-10-14 | Sagami Chem Res Center | トリフルオロメチルケトン誘導体及びホスホリパーゼa2阻害剤 |
| US6262119B1 (en) * | 1996-04-12 | 2001-07-17 | Peptide Technology Limited | Methods of treating immunopathologies using polyunsaturated fatty acids |
| EP1140791A2 (en) | 1997-09-23 | 2001-10-10 | Bristol-Myers Squibb Company | Selective cpla 2 inhibitors |
| US6107334A (en) | 1998-02-23 | 2000-08-22 | Wake Forest University | Dietary control of arachidonic acid metabolism |
| US7605149B1 (en) | 1998-07-13 | 2009-10-20 | University Of South Florida | Modulation of the phospholipase A2 pathway as a therapeutic |
| US6031014A (en) | 1998-12-08 | 2000-02-29 | Crivello; James V. | Initiator compositions and methods for their synthesis and use |
| DE60032774D1 (de) | 1999-07-19 | 2007-02-15 | Lilly Co Eli | Spla2 inhibitoren |
| WO2002060535A1 (en) * | 2001-01-31 | 2002-08-08 | Leff Alan R | Method of treating inflammatory conditions by inhibiting cytosolic phospholipase a¿2? |
| EP1243524A3 (en) | 2001-03-16 | 2004-04-07 | Pfizer Products Inc. | Pharmaceutical kit for oxygen-sensitive drugs |
| US7101875B2 (en) * | 2001-12-03 | 2006-09-05 | Wyeth | Methods for treating arthritic disorders |
| MY131170A (en) | 2002-03-28 | 2007-07-31 | Nissan Chemical Ind Ltd | Therapeutic agent for glomerular disease |
| US20040111957A1 (en) | 2002-12-13 | 2004-06-17 | Filippini Brian B. | Water blended fuel composition |
| WO2006106438A2 (en) * | 2005-01-11 | 2006-10-12 | Evolva Sa | Modulators of ppar activity |
| EP2114397A4 (en) | 2006-12-20 | 2013-06-12 | Medwell Lab Ltd | NEW CONJUGATES OF MULTIPLE UNSATURATED FATTY ACIDS WITH AMINES AND ITS THERAPEUTIC USES |
| NZ552238A (en) | 2006-12-20 | 2009-07-31 | Seperex Nutritionals Ltd | An extract |
| EP2207543A2 (en) * | 2007-09-14 | 2010-07-21 | Resolvyx Pharmaceuticals, Inc. | Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for treating autoimmune diseases or inhibiting immune function |
| WO2009061208A1 (en) | 2007-11-09 | 2009-05-14 | Pronova Biopharma Norge As | Lipid compounds for use in cosmetic products, as food supplement or as a medicament |
| EP2147910A1 (en) | 2008-07-15 | 2010-01-27 | Pronova BioPharma Norge AS | Novel lipid compounds |
| KR101783817B1 (ko) * | 2009-05-08 | 2017-10-23 | 프로노바 바이오파마 너지 에이에스 | 심혈관 질병, 대사 질병, 및 염증성 질환 분야관련 질병의 치료를 위한 다중 불포화 지방산 |
| WO2011097276A1 (en) * | 2010-02-02 | 2011-08-11 | Martek Biosciences Corporation | Methods and compositions for treating arthritis with docosahexaenoic acid |
-
2010
- 2010-09-02 GB GBGB1014633.0A patent/GB201014633D0/en not_active Ceased
-
2011
- 2011-09-01 KR KR1020137008287A patent/KR20130112880A/ko not_active Abandoned
- 2011-09-01 CA CA2810102A patent/CA2810102A1/en not_active Abandoned
- 2011-09-01 CN CN201811592300.8A patent/CN109893518A/zh active Pending
- 2011-09-01 WO PCT/EP2011/065123 patent/WO2012028688A1/en not_active Ceased
- 2011-09-01 JP JP2013526475A patent/JP6082347B2/ja not_active Expired - Fee Related
- 2011-09-01 CN CN2011800520405A patent/CN103249408A/zh active Pending
- 2011-09-01 AU AU2011298340A patent/AU2011298340B2/en not_active Ceased
- 2011-09-01 EP EP11757227.1A patent/EP2611432A1/en not_active Ceased
-
2013
- 2013-02-27 IL IL224963A patent/IL224963A/en active IP Right Grant
- 2013-03-01 US US13/783,088 patent/US9682930B2/en not_active Expired - Fee Related
-
2016
- 2016-11-04 JP JP2016216524A patent/JP2017075148A/ja not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003063878A1 (en) * | 2002-01-29 | 2003-08-07 | Leiv Eiriksson Nyskaping As | Use of polyunsaturated ketones for the treatment of psoriasis |
| WO2006096579A1 (en) * | 2005-03-04 | 2006-09-14 | Abbott Laboratories | Nutritional products for ameliorating symptoms of rheumatoid arthristis |
| US20090192201A1 (en) * | 2008-01-28 | 2009-07-30 | Guillermo Selman-Housein Sosa | Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
| WO2010139482A1 (en) * | 2009-06-04 | 2010-12-09 | Avexxin As | Glomerulonephritis treatment |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011298340A1 (en) | 2013-03-28 |
| EP2611432A1 (en) | 2013-07-10 |
| CN103249408A (zh) | 2013-08-14 |
| IL224963A (en) | 2017-09-28 |
| KR20130112880A (ko) | 2013-10-14 |
| JP6082347B2 (ja) | 2017-02-15 |
| US9682930B2 (en) | 2017-06-20 |
| CA2810102A1 (en) | 2012-03-08 |
| JP2017075148A (ja) | 2017-04-20 |
| US20130245127A1 (en) | 2013-09-19 |
| GB201014633D0 (en) | 2010-10-13 |
| WO2012028688A1 (en) | 2012-03-08 |
| JP2013540713A (ja) | 2013-11-07 |
| CN109893518A (zh) | 2019-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9682930B2 (en) | Rheumatoid arthritis treatment | |
| CA2764465C (en) | Glomerulonephritis treatment | |
| GB1578452A (en) | Pharmaceutical or veterinary formulations or compositions containing anthraquinone derivatives | |
| WO2016159577A2 (ko) | 1,2 나프토퀴논 유도체 및 이의 제조방법 | |
| US11149014B2 (en) | Method for treating pain or associated condition or symptom | |
| CN1678323A (zh) | 多不饱和酮类在银屑病治疗中的应用 | |
| EP1142870A1 (en) | Novel ligands of nuclear receptor | |
| CN103848798B (zh) | 2-芳基硒唑化合物及其药物组合物 | |
| EP1751096A2 (en) | Salt of 4- or 5- aminosalicylic acid | |
| EP3429572B1 (en) | Combination therapy for proliferative diseases | |
| CN105837425B (zh) | (2e, 6e)-2-(3,5-二甲氧基苯基亚甲基)-6-(4-氯苯基亚甲基)环己酮及其衍生物的新应用 | |
| CN105272984A (zh) | 吡唑并[3,4-d]嘧啶-4-酮衍生物、其制备方法和应用 | |
| CN111303161B (zh) | 嘧啶并氮杂环类化合物及其用途 | |
| WO2022238741A1 (en) | Coumarin compounds and a process for preparation thereof | |
| US20090270470A1 (en) | Compounds I | |
| CN121197130A (zh) | 苯丙酸作为PPAR-γ激动剂在制备预防、缓解和/或治疗肠炎产品中的应用 | |
| US20210052537A1 (en) | Colitis ameliorating agent | |
| EP1881826A1 (en) | Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) | |
| JP2006169176A (ja) | 抗コロナウイルス活性を有するインドリル−ペンテン−ジオン誘導体 | |
| CN106459053B (zh) | 吡唑并[3,4-d]嘧啶-4-酮衍生物、其制备方法和应用 | |
| CN122070919A (zh) | 一种ClpP激动剂的新用途 | |
| CN102100684A (zh) | 开环异落叶松脂素在制备治疗抑郁症、焦虑症的药物中的应用 | |
| JPH02247122A (ja) | 抗炎症剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |